ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Combating the SARS-CoV-2 Omicron (BA.1) and BA.2 with potent bispecific antibodies engineered from non-Omicron neutralizing antibodies

Wang, Yingdan; Zhang, Xiang; Ma, Yunping; Wang, Yanqun; Zhan, Wuqiang; Zheng, Qinwen; Zhang, Meng; Ji, Ping; Liu, Mei; Liu, Qianying; Sun, Tingting; Zhu, Tongyu; Wen, Yumei; Sun, Lei*; Zhao, Jincun*; Wu, Fan*; Chen, Zhenguo*; Huang, Jinghe*复旦大学; 广州医学院; 上海交通大学; 中国医学科学院; 1; 5
Cell Discovery2022-10-7DOI: 10.1038/s41421-022-00463-6
8被引6阅读
引用收藏
分享

摘要

The highly mutated and transmissible Omicron (BA.1) and its more contagious lineage BA.2 have provoked serious concerns over their decreased sensitivity to the current COVID-19 vaccines and evasion from most anti-SARS-CoV-2 neutralizing antibodies (NAbs). In this study, we explored the possibility of combating the Omicron and BA.2 by constructing bispecific antibodies based on non-Omicron NAbs. We engineered 10 IgG-like bispecific antibodies with non-Omicron NAbs named GW01, 16L9, 4L12, and REGN10987 by fusing the single-chain variable fragments (scFvs) of two antibodies through a linker and then connecting them to the Fc region of IgG1. Surprisingly, 8 out of 10 bispecific antibodies showed high binding affinities to the Omicron receptor-binding domain (RBD) and exhibited extreme breadth and potency against pseudotyped SARS-CoV-2 variants of concern (VOCs) including Omicron and BA.2, with geometric mean of 50% inhibitory concentration (GM IC50) values ranging from 4.5 ng/mL to 103.94 ng/mL, as well as the authentic BA.1.1. Six bispecific antibodies containing the cross-NAb GW01 not only neutralized Omicron and BA.2, but also neutralized the sarbecoviruses including SARS-CoV and SARS-related coronaviruses (SARSr-CoVs) RS3367 and WIV1, with GM IC50 ranging from 11.6 ng/mL to 103.9 ng/mL. Mapping analyses of 42 spike (S) variant single mutants of Omicron and BA.2 elucidated that these bispecific antibodies accommodated the S371L/F mutations, which were resistant to most of the non-Omicron NAbs. A cryo-electron microscopy (cryo-EM) structure study of the representative bispecific antibody GW01-16L9 (FD01) in its native full-length IgG form in complex with the Omicron S trimer revealed 5 distinct trimers and one novel trimer dimer conformation. 16L9 scFv binds the receptor-binding motif (RBM), while GW01 scFv binds a epitope outside the RBM. Two scFvs of the bispecific antibody synergistically induced the RBD-down conformation into 3 RBD-up conformation, improved the affinity between IgG and the Omicron RBD, induced the formation of trimer dimer, and inhibited RBD binding to ACE2. The trimer dimer conformation might induce the aggregation of virions and contribute to the neutralization ability of FD01. These novel bispecific antibodies are strong candidates for the treatment and prevention of infection with the Omicron, BA.2, VOCs, and other sarbecoviruses. Engineering bispecific antibodies based on non-Omicron NAbs could turn the majority of NAbs into a powerful arsenal to aid the battle against the pandemic.

学科与关键词

关键词
CONVALESCENT
相关
加载中…
  • A Bispecific Antibody Targeting RBD and S2 Potently Neutralizes SARS-CoV-2 Omicron and Other Variants of Concern
    Yuan, Mengqi; Chen, Xiangyu; Zhu, Yanzhi; Dong, Xiaoqing; Liu, Yan; Qian, Zhaohui*; Ye, Lilin*; Liu, Pinghuang*Journal of Virology, 2022, 96(16).被引 6
  • Novel sarbecovirus bispecific neutralizing antibodies with exceptional breadth and potency against currently circulating SARS-CoV-2 variants and sarbecoviruses
    Wang, Yingdan; Liu, Meiqin; Shen, Yaping; Ma, Yunping; Li, Xiang; Zhang, Yuanyuan; Liu, Mei; Yang, Xing-Lou; Chen, Jun; Yan, Renhong; Luan, Die; Wang, Yanqun; Chen, Ying; Wang, Qimin; Lin, Haofeng; Li, Yaning; Wu, Kaiyue; Zhu, Tongyu; Zhao, Jincun; Lu, Hongzhou; Wen, Yumei; Jiang, Shibo; Wu, Fan; Zhou, Qiang; Shi, Zheng-Li; Huang, JingheCell Discovery, 2022, 8(1): 36.被引 18
  • Biparatopic antibody BA7208/7125 effectively neutralizes SARS-CoV-2 variants including Omicron BA.1-BA.5
    Wang, Yanqun; Yan, An; Song, Deyong; Dong, Chuangchuang; Rao, Muding; Gao, Yuanzhu; Qi, Ruxi; Ma, Xiaomin; Wang, Qiaoping; Xu, Hongguang; Liu, Hong; Han, Jing; Duan, Maoqin; Liu, Shuo; Yu, Xiaoping; Zong, Mengqi; Feng, Jianxia; Jiao, Jie; Zhang, Huimin; Li, Min; Yu, Beibei; Wang, Yanxia; Meng, Fanhao; Ni, Xiaodan; Li, Ying; Shen, Zhenduo; Sun, Baiping; Shao, Xin; Zhao, Haifeng; Zhao, Yanyan; Li, Rui; Zhang, Yanan; Du, Guangying; Lu, Jun; You, Chunna; Jiang, Hua; Zhang, Lu; Wang, Lan*Cell Discovery, 2023, 9(1): 3.被引 7
查看全部 →

发表信息

论文状态
公开发表
期刊
Cell Discovery
发表日期
2022-10-07
卷期
第 8 卷, 第 1 期
页码
104
DOI
10.1038/s41421-022-00463-6
期刊等级
1区
成果收录
SCIE
资助标注
Shanghai Municipal Science and Technology Major Project [ZD2021CY001]; National Natural Science Foundation of China [31771008, 3197014]; National Science and Technology Major Project of China [2017ZX10202102, 2018ZX10301403]; Ministry of Science and Technology of China [2021YFC2302500]; Shanghai Municipal Commission of Health and Family Planning [2018BR08]; Chinese Academy of Medical Sciences [2019PT350002]

作者

  • W

    Wang, Yingdan (第一作者)

    5 · b · fudan univ · cams

  • Z

    Zhang, Xiang

    5 · b · fudan univ · cams

查看全部 18 位作者收起作者
  • M

    Ma, Yunping

    5 · b · fudan univ · shanghai jiao tong univ · cams

  • W

    Wang, Yanqun

    1 · guangzhou med univ

  • Z

    Zhan, Wuqiang

    5 · b · fudan univ · cams

  • Z

    Zheng, Qinwen

    5 · b · fudan univ · cams

  • Z

    Zhang, Meng

    5 · b · fudan univ · cams

  • J

    Ji, Ping

    5 · b · fudan univ · cams

  • L

    Liu, Mei

    5 · b · fudan univ · cams

  • L

    Liu, Qianying

    5 · b · fudan univ · cams

  • S

    Sun, Tingting

    5 · b · fudan univ · cams

  • Z

    Zhu, Tongyu

    5 · b · fudan univ · cams

  • W

    Wen, Yumei

    5 · b · fudan univ · cams

  • S

    Sun, Lei (通讯)

    5 · b · fudan univ · cams

  • Z

    Zhao, Jincun (通讯)

    guangzhou med univ · 1

  • W

    Wu, Fan (通讯)

    shanghai jiao tong univ

  • C

    Chen, Zhenguo (通讯)

    5 · b · fudan univ · cams

  • H

    Huang, Jinghe (通讯)

    5 · b · fudan univ · cams

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417